Laboratory centrifuge market seen reaching $2.22 billion by 2030

The laboratory centrifuge market is projected to rise from $1.74 billion in 2026 to $2.22 billion by 2030, driven by biomedical research, diagnostic testing and demand for automated systems. North America led the market in 2025, while infectious disease outbreaks continue to boost testing needs worldwide.

Why it matters: - Laboratory centrifuges sit at the center of research and diagnostic workflows, so rising demand signals broader growth in biomedical testing, molecular diagnostics and life sciences investment. - The market’s projected climb to $2.22 billion by 2030 points to sustained spending on lab automation, sample processing and equipment that protects sample integrity.

What happened: - The Business Research Company released its Laboratory Centrifuge Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035. - The report says the laboratory centrifuge market rose from $1.64 billion in 2025 to an expected $1.74 billion in 2026. - The market is projected to reach $2.22 billion by 2030, reflecting a 6.3% CAGR during the forecast period. - The company also posted a free sample of the report and the full laboratory centrifuge market report.

The details: - Laboratory centrifuges separate components in a solution by density using centrifugal force. - The systems are used in research laboratories, hospitals and other facilities that process liquid samples. - Common applications include separating cells, organelles, viruses, proteins and nucleic acids. - Historical growth was driven by biomedical research, broader hospital diagnostic testing, increased genomics use, advanced lab infrastructure and higher clinical sample volumes. - Forecast growth is linked to automated centrifuge systems, molecular diagnostics, precision medicine, life sciences research spending and efforts to improve lab efficiency. - Key trends include high-speed centrifuges, refrigerated and ultracentrifuge models, digital control systems, compact benchtop designs and stronger focus on sample integrity. - Infectious disease outbreaks are a major demand driver because they increase diagnostic testing and research needs. - The report cites SARS, Zika, Ebola and COVID-19 as examples of outbreaks that raised the global infection burden. - The report notes that about 60% of known human pathogens and up to 75% of emerging pathogens originate from zoonotic infections. - Climate change is altering pathogen and vector ranges, which is increasing pressure on lab testing systems. - The UK Health Security Agency reported in August 2024 that measles cases in England rose to 368 in 2023 from 53 in 2022. - The West Midlands and London accounted for a significant share of those measles cases. - North America was the largest regional market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The latest 2026 market reports from The Business Research Company include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis.

Between the lines: - The demand story is broader than one product category. More infectious disease testing, more genomics work and more automation all push labs toward faster and more specialized centrifuge systems. - The regional lead in North America suggests the market still follows healthcare infrastructure and research intensity, but the disease burden cited in the report points to growth opportunities elsewhere.

What's next: - The market is expected to keep expanding through 2030 as automated and high-performance centrifuges gain share. - Growth should track continued investment in molecular diagnostics, precision medicine and lab productivity upgrades. - Regional demand will likely vary with healthcare spending, research capacity and infectious disease prevalence.

The bottom line: - Laboratory centrifuges are moving from a steady lab tool to a growth market tied to diagnostics, automation and biomedical research.